Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT00001287 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Demyelinating Diseases
Paraproteinemias

Interventions

DRUG: intravenous immunoglobulin (IVIg)

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)